Developing an expanded vector control toolbox for malaria elimination

BMJ Global Health

Volumn 2, Issue 2, 2017, Pages

  Killeen, Gerry F ^a,b   Tatarsky, Allison ^c   Diabate, Abdoulaye ^d   Chaccour, Carlos J ^e,f   Marshall, John M ^g   Okumu, Fredros O ^a,h   Brunner, Shannon ^c   Newby, Gretchen ^c   Williams, Yasmin A ^c   Malone, David ⁱ   Tusting, Lucy S ^j   Gosling, Roland D ^c  

^a IFAKARA HEALTH INSTITUTE   (Tanzania)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CENTRE MURAZ   (Burkina Faso)

^e CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^f UNIVERSITY OF NAVARRA   (Spain)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF THE WITWATERSRAND   (South Africa)

ⁱ Innovative Vector Control Consortium   (United Kingdom)

^j UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85031006939     PISSN: None     EISSN: 20597908     Source Type: Journal    
DOI: 10.1136/bmjgh-2016-000211     Document Type: Article

References (85)

1. Bhatt S, Weiss DJ, Cameron E, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature 2015;526:207–11.
2. WHO. World Malaria Report 2015. Geneva: World Health Organization, 2015:243.
3. Gates W, Chambers R. Aspiration to action: what will it take to end malaria? 2015:60. http://endmalaria2040.org/assets/Aspiration-toAction.pdf
4. WHO. Global technical strategy for malaria for 2016–2030. Geneva: World Health Organization, Global Malaria Programme, 2015:32.
5. Killeen GF. Characterizing, controlling and eliminating residual malaria transmission. Malar J 2014;13:330.
6. Killeen GF, Kiware SS, Okumu FO, et al. Going beyond personal protection against mosquito bites to eliminate malaria transmission: population suppression of malaria vectors that exploit both human and animal blood. BMJ Global Health 2016;2:e000198.
7. Challet GL. Mosquito abatement district programs in the United States. Gaoxiong Yi Xue Ke Xue Za Zhi 1994;10 Suppl:S67–73.
8. Dale PE, Carlson DB, Easton CS. Four degrees of latitude: mosquito control on the “right” coasts of Australia and Florida, USA. J Am Mosq Control Assoc 2008;24:427–37.
9. WHO. Larval source management-A supplementary measure for malaria vector control: an operational manual. Geneva: World Health Organization, 2013:116.
10. Tusting LS, Thwing J, Sinclair D, et al. Mosquito larval source management for controlling malaria. Cochrane Database Syst Rev 2013;(8):CD008923.
11. Smith Gueye C, Newby G, Gosling RD, et al. Strategies and approaches to vector control in nine malaria-eliminating countries: a cross-case study analysis. Malar J 2016;15:2.
12. Hemingway J, Ranson H, Magill A, et al. Averting a malaria disaster: will insecticide resistance derail malaria control? Lancet 2016;387: 1785–8.
13. Ranson H, Lissenden N. Insecticide resistance in African Anopheles mosquitoes: a worsening situation that needs urgent action to maintain malaria control. Trends Parasitol 2016;32:187–96.
14. WHO. Insecticide treated mosquito nets: a position statement. Geneva: Global Malaria Programme; World Health Organization, 2007:10.
15. Killeen GF, Smith TA, Ferguson HM, et al. Preventing childhood malaria in Africa by protecting adults from mosquitoes with insecticide-treated nets. PLoS Med 2007;4:e229.
16. Mnzava AP, Knox TB, Temu EA, et al. Implementation of the global plan for insecticide resistance management in malaria vectors: progress, challenges and the way forward. Malar J 2015;14:173.
17. Oxborough R. Trends in US President’s Malaria Initiative-funded indoor residual spray coverage and insecticide choice in Sub-Saharan Africa (2008–2015): urgent need for affordable, long-lasting insecticides. Malar J 2016;15:146.
18. Chanda E, Mzilahowa T, Chipwanya J, et al. Preventing malaria transmission by indoor residual spraying in Malawi: grappling with the challenge of uncertain sustainability. Malar J 2015;14:254.
19. WHO. Guidance note—control of residual malaria parasite transmission. World Health Organization Global Malaria Programme, 2014:5.
20. Mnyone LL, Lyimo IN, Lwetoijera DW, et al. Exploiting the behaviour of wild malaria vectors to achieve high infection with fungal biocontrol agents. Malar J 2012;11:87.
21. Sternberg ED, Ng’habi KR, Lyimo IN, et al. Eave tubes for malaria control in Africa: initial development and semi-field evaluations in Tanzania. Malar J 2016;15:447.
22. Killeen GF, Masalu JP, Chinula D, et al. Insecticide-treated combinations of window screens and eave baffles may help control physiologically and behaviorally resistant malaria vector mosquitoes. Emerg Infect Dis 2017;23:782–89.
23. WHO. Global plan for insecticide resistance management in malaria vectors (GPIRM). Geneva: Global Malaria Control Programme, 2012:130.
24. Farenhorst M, Mouatcho JC, Kikankie CK, et al. Fungal infection counters insecticide resistance in African malaria mosquitoes. Proc Natl Acad Sci USA 2009;106:17443–7.
25. Bhatt S, Weiss DJ, Mappin B, et al. Coverage and system efficiencies of insecticide-treated nets in Africa from 2000 to 2017. eLife 2015;4:e09672.
26. WHO. WHO malaria terminology. 2016:31.
27. Lwetoijera D, Harris C, Kiware S, et al. Effective autodissemination of pyriproxyfen to breeding sites by the exophilic malaria vector Anopheles arabiensis in semi-field settings in Tanzania. Malar J 2014;13:161.
28. Hammond A, Galizi R, Kyrou K, et al. A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae. Nat Biotech 2016;34:78–83.
29. Shaw WR, Marcenac P, Childs LM, et al. Wolbachia infections in natural Anopheles populations affect egg laying and negatively correlate with Plasmodium development. Nature Comm 2016;7:11772.
30. Ouédraogo AL, Bastiaens GJ, Tiono AB, et al. Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial. Clin Infect Dis 2015;60:357–65.
31. Chaccour CJ, Kobylinski KC, Bassat Q, et al. Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination. Malar J 2013;12:153.
32. Kitron U, Spielman A. Suppression of transmission of malaria through source reduction: antianopheline measures applied in Israel, the United States, and Italy. Rev Infect Dis 1989;11:391–406.
33. Lindsay SW, Emerson PM, Charlwood JD. Reducing malaria by mosquito-proofing homes. Trends Parasitol 2002;18:510–14.
34. Chaki PP, Kannady K, Mtasiwa D, et al. Institutional evolution of a community-based programme for malaria control through larval source management in Dar es Salaam, United Republic of Tanzania. Malar J 2014;13:245.
35. Worrall E, Fillinger U. Large-scale use of mosquito larval source management for malaria control in Africa: a cost analysis. Malar J 2011;10:338.
36. Dambach P, Schleicher M, Stahl HC, et al. Routine implementation costs of larviciding with Bacillus thuringiensis israelensis against malaria vectors in a district in rural Burkina Faso. Malar J 2016;15:380.
37. Rahman R, Lesser A, Mboera L, et al. Cost of microbial larviciding for malaria control in rural Tanzania. Trop Med Int Health 2016;21:1468–75.
38. Fillinger U, Ndenga B, Githeko A, et al. Integrated malaria vector control with microbial larvicides and insecticide-treated nets in western Kenya: a controlled trial. Bull World Health Organ 2009;87:655–65.
39. Sawadogo SP, Niang A, Bilgo E, et al. Targeting male mosquito swarms to control malaria vector density. PLoS ONE 2017;12: e0173273.
40. Ferguson HM, Dornhaus A, Beeche A, et al. Ecology: a prerequisite for malaria elimination and eradication. PLoS Med 2010;7:e1000303.
41. Killeen GF, Seyoum A, Gimnig JE, et al. Made-to-measure malaria vector control strategies: rational design based on insecticide properties and coverage of blood resources for mosquitoes. Malar J 2014;13:146.
42. Killeen GF, Marshall JM, Kiware SS, et al. Measuring, manipulating and exploiting behaviours of adult mosquitoes to optimize malaria vector control impact. BMJ Global Health 2016;2:e000212.
43. Colatrella B. The Mectizan Donation Program: 20 years of successful collaboration—a retrospective. Ann Trop Med Parasitol 2008;102(Suppl 1):7–11.
44. Chaccour C, Killeen GF. Mind the gap: residual malaria transmission, veterinary endectocides and livestock as targets for malaria vector control. Malar J 2016;15:24.
45. Wilson AL, Boelaert M, Kleinschmidt I, et al. Evidence-based vector control? Improving the quality of vector control trials. Trends Parasitol 2015;31:380–90.
46. Bowman LR, Donegan S, McCall PJ. Is dengue vector control deficient in effectiveness or evidence? A systematic review and meta-analysis. PLoS Negl Trop Dis 2016;10:e0004551.
47. Bonds JA. Ultra-low-volume space sprays in mosquito control: a critical review. Med Vet Entomol 2012;26:121–30.
48. Itoh T, Marijani JH, Keto AJ, et al. Control of Anopheles mosquitoes by ultra-low volume applications of d-allethrin and d-phenothrin in combination with larvicidings of fenitrothion in Tanzania. J Am Mosq Control Assoc 1988;4:563–4.
49. Hobbs JH. A trial of ultra-low volume pyrethrin spraying as a malaria control measure in El Salvador. Mosquito News 1976;36:132–7.
50. Roll Back Malaria Vector Control Working Group. Consensus statement on housing and malaria. Geneva: Roll Back Malaria Partnership-United Nations Development Program-United Nations Habitat, 2015:7.
51. Ogoma SB, Kannady K, Sikulu M, et al. Window screening, ceilings and closed eaves as sustainable ways to control malaria in Dar es Salaam, Tanzania. Malar J 2009;8:221.
52. Swai JK, Finda MF, Madumla EP, et al. Studies on mosquito biting risk among migratory rice farmers in rural south-eastern Tanzania and development of a portable mosquito-proof hut. Malar J 2016;15:564.
53. Tungu PK, Malima R, Mosha FW, et al. Evaluation of Icon Maxx, a long-lasting treatment kit for mosquito nets: experimental hut trials against anopheline mosquitoes in Tanzania. Malar J 2015;14:225.
54. Andriessen R, Snetselaar J, Suer RA, et al. Electrostatic coating enhances bioavailability of insecticides and breaks pyrethroid resistance in mosquitoes. Proc Natl Acad Sci USA 2015;112:12081–6.
55. Diabaté A, Bilgo E, Dabiré RK, et al. Environmentally friendly tool to control mosquito populations without risk of insecticide resistance: the Lehmann’s funnel entry trap. Malar J 2013;12:196.
56. Macintyre K, Sosler S, Letipila F, et al. A new tool for malaria prevention? Results of a trial of permethrin-impregnated bedsheets (shukas) in an area of unstable transmission. Int J Epidemiol 2003;32:157–60.
57. Kitau J, Oxborough R, Kaye A, et al. Laboratory and experimental hut evaluation of a long-lasting insecticide treated blanket for protection against mosquitoes. Parasit Vectors 2014;7:129.
58. Deressa W, Yihdego YY, Kebede Z, et al. Effect of combining mosquito repellent and insecticide treated net on malaria prevalence in Southern Ethiopia: a cluster-randomised trial. Parasit Vectors 2014;7:132.
59. Sluydts V, Durnez L, Heng S, et al. Efficacy of topical mosquito repellent (picaridin) plus long-lasting insecticidal nets versus long-lasting insecticidal nets alone for control of malaria: a cluster randomised controlled trial. Lancet Infect Dis 2016;16:1169–77.
60. Grieco JP, Achee NL, Chareonviriyaphap T, et al. A new classification system for the actions of IRS chemicals traditionally used for malaria control. PLoS ONE 2007;2:e716.
61. Moore SJ, Davies C, Cameron MM. Are mosquitoes diverted from repellent-using individuals to non-users? Results of a field study in Bolivia. Trop Med Int Health 2007;12:532–9.
62. Maia MF, Onyango SP, Thele M, et al. Do topical repellents divert mosquitoes within a community? Health equity implications of topical repellents as a mosquito bite prevention tool. PLoS ONE 2013;8: e84875.
63. Killeen GF, Moore SJ. Target product profiles for protecting against outdoor malaria transmission. Malar J 2012;11:17.
64. Achee NL, Bangs MJ, Farlow R, et al. Spatial repellents: from discovery and development to evidence-based validation. Malar J 2012;11:164.
65. Ogoma SB, Ngonyani H, Simfukwe ET, et al. The mode of action of spatial repellents and their impact on vectorial capacity of Anopheles gambiae sensu stricto. PLoS ONE 2014;9:e110433.
66. Govella NJ, Ogoma SB, Paliga J, et al. Impregnating hessian strips with the volatile pyrethroid transfluthrin prevents outdoor exposure to vectors of malaria and lymphatic filariasis in urban Dar es Salaam, Tanzania. Parasit Vectors 2015;8:322.
67. Ogoma SB, Mmando AS, Swai JK, et al. A low technology emanator treated with the volatile pyrethroid transfluthrin confers long term protection against outdoor biting vectors of lymphatic filariasis, arboviruses and malaria. PLoS Negl Trop Dis 2017;11: e0005455.
68. Masalu JP, Finda M, Okumu FO, et al. Efficacy and user acceptability of transfluthrin-treated sisal and hessian decorations for protecting against mosquito bites in outdoor bars. Parasit Vectors 2016; in press.
69. WHO. Guidelines for efficacy testing of spatial repellents. Geneva: World Health Organization, 2013.
70. Horstmann S, Sonneck R, Velten R, et al. United States of America patent US 2015/0289513 A1. 15 Oct 2015.
71. Homan T, Hiscox A, Mweresa CK, et al. The effect of mass mosquito trapping on malaria transmission and disease burden (SolarMal): a stepped-wedge cluster-randomised trial. Lancet 2016;388:1193–201.
72. Killeen GF. Mass trapping of malaria vector mosquitoes. Lancet 2016;388:1136–7.
73. Garrett-Jones C, Boreham P, Pant CP. Feeding habits of anophelines (Diptera: Culicidae) in 1971-78, with reference to the human blood index: a review. Bull Entomol Res 1980;70:165–85.
74. Butters MP, Kobylinski KC, Deus KM, et al. Comparative evaluation of systemic drugs for their effects against Anopheles gambiae. Acta Trop 2012;121:34–43.
75. Rowland M, Durrani N, Kenward M, et al. Control of malaria in Pakistan by applying deltamethrin insecticide to cattle: a community-randomised trial. Lancet 2001;357:1837–41.
76. Killeen GF, Kiware SS, Seyoum A, et al. Comparative assessment of diverse strategies for malaria vector population control based on measured rates at which mosquitoes utilize targeted resource subsets. Malar J 2014;13:338.
77. Bardosh K, Waiswa C, Welburn SC. Conflict of interest: use of pyrethroids and amidines against tsetse and ticks in zoonotic sleeping sickness endemic areas of Uganda. Parasit Vectors 2013;6:204.
78. Qualls WA, Müller GC, Traore SF, et al. Indoor use of attractive toxic sugar bait (ATSB) to effectively control malaria vectors in Mali, West Africa. Malar J 2015;14:301.
79. Junnila A, Revay EE, Müller GC, et al. Efficacy of attractive toxic sugar baits (ATSB) against Aedes albopictus with garlic oil encapsulated in beta-cyclodextrin as the active ingredient. Acta Trop 2015;152:195–200.
80. Revay EE, Schlein Y, Tsabari O, et al. Formulation of attractive toxic sugar bait (ATSB) with safe EPA-exempt substance significantly diminishes the Anopheles sergentii population in a desert oasis. Acta Trop 2015;150:29–34.
81. Diabate A, Tripet F. Targeting male mosquito mating behaviour for malaria control. Parasit Vectors 2015;8:347.
82. Nájera JA. Malaria control: achievements, problems and strategies. Parassitologia 2001;43:1–89.
83. Hougard JM, Yaméogo L, Sékétéli A, et al. Twenty-two years of blackfly control in the onchocerciasis control programme in West Africa. Parasitol Today (Regul Ed) 1997;13:425–31.
84. Dias JC, Silveira AC, Schofield CJ. The impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz 2002;97:603–12. [Published Online First: 2002/09/10].
85. Torr SJ, Hargrove JW, Vale GA. Towards a rational policy for dealing with tsetse. Trends Parasitol 2005;21:537–41.